2659 — Shanghai Bao Pharmaceuticals Co Share News
0.000.00%
Last trade - 00:00- HK$5.35bn
- HK$4.28bn
- CNY49.16m
Brief: Shanghai Bao Pharmaceuticals Says NMPA Accepts NDA For KJL03 For Injection
Brief: Shanghai Bao Pharmaceuticals Says NMPA Approves Human Hyaluronidase For Injection For Marketing
Shanghai Bao at nearly 4-week high on China regulator nod to new product
Brief: Shanghai Bao Pharmaceuticals Proposes To Elect Liu Yanjun, Wang Zheng, Li Cui As Executive Directors
Shanghai Bao Pharmaceuticals jumps after China clinical trial nod for gastroscopy product
Shanghai Bao Pharmaceuticals shines in Hong Kong debut
Brief: Shanghai Bao Pharmaceuticals Announces Final Offer Price HK$26.38 Per H Share Under Offering